CDER New January 23, 2016

New FDA Logo Blue

What's New on the FDA Drugs Site

 

January 19, 2017


New and Generic Drug Approvals

January 18, 2017

Drug Name and
Application Number
Active Ingredient Dosage Form/ Route Submission Company Submission Classification Submission Status
Aspirin and Dipyridamole
ANDA #206739
Aspirin; Dipyridamole Capsule, Extended Release; Oral ORIG-1 Sandoz Inc   Approved
Benlysta
BLA #125370
Belimumab Injectable; Injection SUPPL-57 Human Genome Sciences Inc. LABELING Approved
Clindesse
NDA #050793
Clindamycin Phosphate Cream; Vaginal SUPPL-22 Perrigo Pharma Intl MANUF (CMC) Approved
Imbruvica
NDA #205552
Ibrutinib Capsule; Oral SUPPL-16 Pharmacyclics Inc EFFICACY Approved
Janumet
NDA #022044
Metformin Hydrochloride; Sitagliptin Phosphate Tablet; Oral SUPPL-39 Merck Sharp Dohme LABELING Approved
Janumet
NDA #022044
Metformin Hydrochloride; Sitagliptin Phosphate Tablet; Oral SUPPL-40 Merck Sharp Dohme LABELING Approved
Janumet Xr
NDA #202270
Metformin Hydrochloride; Sitagliptin Phosphate Tablet, Extended Release; Oral SUPPL-15 Merck Sharp Dohme LABELING Approved
Janumet Xr
NDA #202270
Metformin Hydrochloride; Sitagliptin Phosphate Tablet, Extended Release; Oral SUPPL-16 Merck Sharp Dohme LABELING Approved
Januvia
NDA #021995
Sitagliptin Phosphate Tablet; Oral SUPPL-38 Merck Sharp Dohme LABELING Approved
Kombiglyze Xr
NDA #200678
Metformin Hydrochloride; Saxagliptin Hydrochloride Tablet, Extended Release; Oral SUPPL-19 Astrazeneca Ab LABELING Approved
Kombiglyze Xr
NDA #200678
Metformin Hydrochloride; Saxagliptin Hydrochloride Tablet, Extended Release; Oral SUPPL-20 Astrazeneca Ab LABELING Approved
Onglyza
NDA #022350
Saxagliptin Hydrochloride Tablet; Oral SUPPL-19 Astrazeneca Ab LABELING Approved
Quetiapine Fumarate
ANDA #206252
Quetiapine Fumarate Tablet, Extended Release; Oral ORIG-1 Accord Hlthcare Inc   Tentative Approval

 

Searching the Orange Book is now faster and easier with our new mobile app!

Download Orange Book Express

 Download iOS App Download Android App Black


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New January 23, 2016"

Post a Comment